Interferon (IFN)- -2b is effective in patients with mild chronic hepatitis C

By  

Inpharma, Vol. 1, Iss. 1279, 2001-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

A Randomised Controlled Trial of IFN-α, IL-2 and 5FU Versus IFN-α Alone in Metastatic Renal Cell Carcinoma (ISRCTN 46518965)*

By  

UroOncology, Vol. 2, Iss. 2, 2002-01 ,pp. : 51-53

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Comparative Pharmacokinetics, Tissue Distribution, Excretion of Recombinant Liver-Targeting Interferon with IFN α2b Administered Intramuscular in Rats

By  

Current Pharmaceutical Biotechnology, Vol. 16, Iss. 10, 2015-01 ,pp. : 911-919

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitory effects of interferon‐β on hepatocellular carcinoma HepG2 via Akt/STAT phosphorylation

By  

Fundamental & Clinical Pharmacology, Vol. 29, Iss. 3, 2015-06 ,pp. : 278-285

John Wiley & Sons Inc

Access to resources Recommend Favorite

Carbon anhydrase IX specific immune responses in patients with metastatic renal cell carcinoma potentially cured by interleukin-2 based immunotherapy

By Rasmussen Susanne   Donskov Frede   Pedersen Johannes W.   Wandall Hans H.   Buus Søren   Harndahl Mikkel   Braendstrup Peter   Claesson Mogens H.   Pedersen Anders Elm  

Immunopharmacology and Immunotoxicology, Vol. 35, Iss. 4, 2013-08 ,pp. : 487-496

Informa Healthcare

Access to resources Recommend Favorite